Tyrosinase 酪氨酸酶（鼠單克隆抗體）

廣州健侖生物科技有限公司

酪氨酸酶(Tyrosinase)又名單酚單氧化酶，催化酚類化合物(如酪氨酸)的氧化，廣泛存在于動植物中。Tyrosinase在黑色素及其他色素的生成過程中起催化作用，存在于黑色體中。其基因的突變會導致I型眼-皮膚白化病（發病率1/17000）。該抗體特異性的表達于黑色素病變組織中，如惡性黑色素瘤、黑色素病變的神經纖維瘤，上皮來源的癌*不表達該抗體。

我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。

歡迎咨詢

歡迎咨詢

Tyrosinase 酪氨酸酶（鼠單克隆抗體）

【產品介紹】

細胞定位：細胞漿

克隆號：T311

同型：IgG

適用組織：石蠟/冰凍

陽性對照：惡性黑色素瘤/皮膚色素痣

抗原修復：熱修復（EDTA）

抗體孵育時間：30-60min

Tyrosinase

想了解更多的產品及服務請掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場部】     歐

【】 
【騰訊  】 
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室

艾布拉姆森癌癥中心研究人員諾埃爾·弗雷說，“我們的試驗結果說明，CTL019療法可以對先前治療失敗的病人產生持久療效，同時不必使用其他補充療法”。這對于接受干細胞移植后癌癥復發或者沒有找到捐獻者的病人來說是一個新的希望。
2014年7月美國食品和藥物管理局賦予CTL019療法“治療學發現”稱號，CTL019療法是*個性化細胞療法，在治療效果上顯示出重大優勢，美國已在多家醫院開始這種療法的測試。
據日本《朝日新聞》16日報道，日本一化妝品公司宣布，成功使用iPS細胞(人工多能干細胞)實現了“返老還童”，將一位67歲日本男性的皮膚細胞恢復到和他本人36歲時的皮膚基本相同狀態。
據悉，該男性自1980年以來，一直定期提供36歲-67歲間五個不同年齡段的皮膚細胞，并由京都大學ips細胞研究所將其轉化為iPS細胞。
經化妝品公司分析，作為老化指標的染色體狀態在五個年齡段均有所恢復，連67歲時采集的皮膚細胞也恢復到了和36歲時大致相同的狀態。
該公司稱，將使用此研究結果闡明皮膚老化機制。目前雖尚處于基礎研究階段，但從長遠來看，這將會推動針對個人、不同敏感源的定制化妝品開發

Noel Frey, a researcher at the Abramson Cancer Center, said, "Our results demonstrate that CTL019 can produce long-lasting effects in previously unsuccessful patients without the need for other complementary therapies." This is a new hope for patients who have relapsed after stem cell transplantation or have not found a donor.
In July 2014, the US Food and Drug Administration awarded the title of "Therapeutics Discovery" to CTL019 Therapy. CTL019 Therapy is the first personalized cell therapy that shows major advantages in treatment effectiveness. The United States has started this therapy in several hospitals test.
According to Japan's "Asahi Shimbun" reported on the 16th, a cosmetics company in Japan announced the successful use of iPS cells (artificial pluripotent stem cells) to achieve "rejuvenation" will be a 67-year-old Japanese male skin cells and his return to 36 years old The skin is basically the same state.
It is reported that since 1980, the man has regularly provided skin cells of five different ages ranging from 36 to 67 years old and has been transformed into iPS cells by the ips cell research institute of Kyoto University.
Analyzed by the Cosmetics Company, the status of chromosomes as an indicator of aging recovered in all five age groups, and the skin cells collected at 67 were also restored to the same state as those at 36 years of age.
The company said it will use the results of this study to elucidate the mechanism of skin aging. Although it is still in the basic research phase, it will promote the development of customized cosmetics targeting individuals and sensitive sources in the long run